VSM Wealth Advisory LLC Makes New Investment in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

VSM Wealth Advisory LLC acquired a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,477 shares of the real estate investment trust’s stock, valued at approximately $26,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Principal Financial Group Inc. boosted its stake in Sabra Health Care REIT by 2.5% during the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust’s stock worth $382,940,000 after buying an additional 536,247 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Sabra Health Care REIT by 222.4% during the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after buying an additional 6,819,919 shares during the last quarter. Geode Capital Management LLC boosted its stake in Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after buying an additional 104,533 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Sabra Health Care REIT by 8.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust’s stock worth $87,502,000 after buying an additional 365,855 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in Sabra Health Care REIT by 13.0% during the fourth quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust’s stock worth $69,967,000 after buying an additional 463,601 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

SBRA stock opened at $17.33 on Friday. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $4.12 billion, a PE ratio of 32.70, a P/E/G ratio of 1.97 and a beta of 1.27. Sabra Health Care REIT, Inc. has a 12-month low of $13.31 and a 12-month high of $20.03. The business’s fifty day moving average price is $16.77 and its 200 day moving average price is $17.67.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. The firm had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, sell-side analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.92%. Sabra Health Care REIT’s dividend payout ratio is presently 226.42%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Mizuho reissued a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research report on Tuesday, January 7th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Finally, Truist Financial lifted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $19.33.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.